Patents by Inventor Giulio Cabrini

Giulio Cabrini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Trimethylangelicin as CFTR corrector in bronchial epithelial cells
    Patent number: 9283206
    Abstract: The invention relates to the use of 4,6,4?-trimethylangelicin (TMA) and structural analogs thereof to prepare a medicament for the treatment of cystic fibrosis with the primary objective of correcting the defective CFTR in a sub-group of cystic fibrosis patients consisting of patients carrying the F508del-CFTR mutation.
    Type: Grant
    Filed: June 13, 2012
    Date of Patent: March 15, 2016
    Assignees: Azienda Ospedaliera Universitaria Integrata di Verona, Universita' degli Studi di Ferrara, Universita' degli Studi di Bari, Rare Partners S.r.l.
    Inventors: Giulio Cabrini, Valeria Casavola, Roberto Gambari
  • TRIMETHYLANGELICIN AS CFTR CORRECTOR IN BRONCHIAL EPITHELIAL CELLS
    Publication number: 20150290167
    Abstract: The invention relates to the use of 4,6,4?-trimethylangelicin (TMA) and structural analogues thereof to prepare a medicament for the treatment of cystic fibrosis with the primary objective of correcting the defective CFTR in a sub-group of cystic fibrosis patients consisting of patients carrying the F508de1-CFTR mutation.
    Type: Application
    Filed: June 13, 2012
    Publication date: October 15, 2015
    Applicants: AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA DI VERONA, RARE PARTNERS S.R.L., UNIVERSITA' DEGLI STUDI DI BARI, UNIVERSITA' DEGLI STUDI DI FERRARA
    Inventors: Giulio Cabrini, Valeria Casavola, Roberto Gambari